Pulmonary Arterial Hypertension (Group 1 Pulmonary Hypertension)
摘要
This chapter reviews the pharmacotherapy for pulmonary arterial hypertension (PAH) based on the 2022 European Society of Cardiology/European Respiratory Society and 2019 CHEST guidelines.